Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02447965 · ClinicalTrials.gov registry record · NA
Pilot Study: Rectus Sheath Blocks for Improving Abdominal Surgery Conditions
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02447965 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 6 participants.
The verdict
NCT02447965, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to show that the use of preoperative rectus sheath blocks can ultimately alleviate the need for using nondepolarizing muscle relaxants during certain abdominal procedures.
Interventions
- DRUG Bupivacaine
- DRUG Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2016-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02447965
The ClinicalTrials.gov registry entry for NCT02447965 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT02447965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02447965 about?
NCT02447965 is a clinical study titled "Pilot Study: Rectus Sheath Blocks for Improving Abdominal Surgery Conditions". The purpose of this study is to show that the use of preoperative rectus sheath blocks can ultimately alleviate the need for using nondepolarizing muscle relaxants during certain abdominal procedures.
What is the current status of trial NCT02447965?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-01-01. Estimated completion is 2016-12-01.
What interventions are being tested in trial NCT02447965?
The interventions under investigation include: Bupivacaine (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT02447965?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.